Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

FDA recall notice · announced October 14, 2026 · Biospectra

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25

Reason for recall

Failed stability specifications

Notes

Distribution: CA
Lot/code information: Lot#: TRIS -E04-0226-0016; Exp 2/29/28
Quantity: 200 kg
Status: Ongoing
Products in this recall event:
- Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25 (D-0012-2027)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.